Journal of Obesity

Research Article

Reversal Rate of Clustering of Cardiovascular Disease Risk Factors of Metabolic Syndrome in the General Population: The Niigata Preventive Medicine Study

Table 1

Baseline characteristics of subjects with (≥3) and without clustering (0–2) of CVD risk factors.
All subjects ( 𝑛 = 3 5 , 5 3 4 )Without clustering ( 𝑛 = 3 0 , 6 2 3 )With clustering ( 𝑛 = 4 , 9 1 1 )
Male (%)32.132.232.1
Age (years) 5 9 . 4 ± 1 0 . 0 5 9 . 1 ± 1 0 . 0 6 1 . 7 ± 9 . 0 ∗
BMI ( ≥ 25 k g / m 2 ) 2 2 . 8 ± 2 . 9 2 2 . 4 ± 2 . 6 2 5 . 7 ± 2 . 8 ∗
Blood pressure (mmHg)
 Systolic ( ≥ 130 m m H g ) 1 2 8 . 7 ± 1 7 . 3 1 2 6 . 9 ± 1 6 . 9 1 4 0 . 5 ± 1 4 . 9 ∗
 Diastolic ( ≥ 85 m m H g ) 7 7 . 4 ± 1 0 . 7 7 6 . 4 ± 1 0 . 5 8 3 . 3 ± 9 . 8 ∗
HDL cholesterol (mg/dl)
 Men ( ≤ 40 m g / d L ) 6 0 . 4 ± 1 5 . 2 6 2 . 3 ± 5 . 5 4 9 . 9 ± 1 3 . 8 ∗
 Women ( ≤ 50 m g / d L ) 6 4 . 9 ± 1 4 . 6 6 6 . 6 ± 1 4 . 5 5 1 . 5 ± 1 3 . 0 ∗
Triglyceride ( ≥ 150 m g / d l ) 1 0 0 . 8 ± 6 5 . 8 9 0 . 1 ± 4 8 . 0 1 6 7 . 7 ± 1 0 8 . 6 ∗
FBG ( ≥ 100 m g / d L ) 9 3 . 2 ± 1 4 . 0 9 1 . 7 ± 1 2 . 1 1 0 2 . 9 ± 1 9 . 7 ∗
BMI: Body mass index. HDL cholesterol: High-density lipoprotein cholesterol. FBG: Fasting blood glucose.